Prevalence of Rathke Cleft and Other Incidental Pituitary Gland Findings on Contrast-Enhanced 3D Fat-Saturated T1 MPRAGE at 7T MRI

References

1. 1.↵
   FDA clears first 7T magnetic resonance imaging device. https://www.fda.gov/news-events/press-announcements/fda-clears-first-7t-magnetic-resonance-imaging-device. Accessed January 11, 2023
2. 2.↵
   Bringing Ultra-High Field MR Imaging from Research to Clinical: SIGNA 7.0T FDA Cleared. https://www.gehealthcare.com/about/newsroom/press-releases/bringing-ultra-high-field-mr-imaging-from-research-to-clinical-signa-70t-fda-cleared?npclid=botnpclid. Accessed December 12, 2023
3. 3.↵
   1. Özütemiz C,
   2. White M,
   3. Elvendahl W, et al

   . Use of a commercial 7-T MRI scanner for clinical brain imaging: indications, protocols, challenges, and solutions-a single-center experience. AJR Am J Roentgenol 2023;221:788–804 doi:10.2214/AJR.23.29342 pmid:37377363

   CrossRefPubMed
4. 4.↵
   1. Okada T,
   2. Fujimoto K,
   3. Fushimi Y, et al

   . Neuroimaging at 7 Tesla: a pictorial narrative review. Quant Imaging Med Surg 2022;12:3406–35 doi:10.21037/qims-21-969 pmid:35655840

   CrossRefPubMed
5. 5.↵
   1. Opheim G,
   2. van der Kolk A,
   3. Markenroth Bloch K, et al

   . 7T epilepsy task force consensus recommendations on the use of 7T MRI in clinical practice. Neurology 2021;96:327–41 doi:10.1212/WNL.0000000000011413 pmid:33361257

   Abstract/FREE Full Text
6. 6.↵
   1. Ugurbil K

   . Magnetic resonance imaging at ultrahigh fields. IEEE Trans Biomed Eng 2014;61:1364–79 doi:10.1109/TBME.2014.2313619 pmid:24686229

   CrossRefPubMed
7. 7.↵
   1. Grams AE,
   2. Kraff O,
   3. Kalkmann J, et al

   . Magnetic resonance imaging of cranial nerves at 7 Tesla. Clin Neuroradiol 2013;23:17–23 doi:10.1007/s00062-012-0144-3 pmid:23015059

   CrossRefPubMed
8. 8.↵
   1. Lecler A,
   2. Duron L,
   3. Charlson E, et al

   . Comparison between 7 Tesla and 3 Tesla MRI for characterizing orbital lesions. Diagn Interv Imaging 2022;103:433–39 doi:10.1016/j.diii.2022.03.007 pmid:35410799

   CrossRefPubMed
9. 9.↵
   1. Ma R,
   2. Henry TR,
   3. Van de Moortele PF

   . Eliminating susceptibility induced hyperintensities in T1w MPRAGE brain images at 7T. Magn Reson Imaging 2019;63:274–79 doi:10.1016/j.mri.2019.08.013 pmid:31446038

   CrossRefPubMed
10. 10.↵
    1. Snaar JE,
    2. Teeuwisse WM,
    3. Versluis MJ, et al

    . Improvements in high-field localized MRS of the medial temporal lobe in humans using new deformable high-dielectric materials. NMR Biomed 2011;24:873–79 doi:10.1002/nbm.1638 pmid:21834010

    CrossRefPubMed
11. 11.↵
    1. Teeuwisse WM,
    2. Brink WM,
    3. Webb AG

    . Quantitative assessment of the effects of high-permittivity pads in 7 Tesla MRI of the brain. Magn Reson Med 2012;67:1285–93 doi:10.1002/mrm.23108 pmid:21826732

    CrossRefPubMed
12. 12.↵
    1. Van de Moortele PF,
    2. Akgun C,
    3. Adriany G, et al

    . B(1) destructive interferences and spatial phase patterns at 7 T with a head transceiver array coil. Magn Reson Med 2005;54:1503–18 doi:10.1002/mrm.20708 pmid:16270333

    CrossRefPubMed
13. 13.↵
    1. Yang QX,
    2. Mao W,
    3. Wang J, et al

    . Manipulation of image intensity distribution at 7.0 T: passive RF shimming and focusing with dielectric materials. J Magn Reson Imaging 2006;24:197–202 doi:10.1002/jmri.20603 pmid:16755543

    CrossRefPubMed
14. 14.↵
    1. Eisenhut F,
    2. Schlaffer SM,
    3. Hock S, et al

    . Ultra-high-field 7 T magnetic resonance imaging including dynamic and static contrast-enhanced T1-weighted imaging improves detection of secreting pituitary microadenomas. Invest Radiol 2022;57:567–74 doi:10.1097/RLI.0000000000000872 pmid:35925660

    CrossRefPubMed
15. 15.↵
    1. Patel V,
    2. Liu CJ,
    3. Shiroishi MS, et al

    . Ultra-high field magnetic resonance imaging for localization of corticotropin-secreting pituitary adenomas. Neuroradiology 2020;62:1051–54 doi:10.1007/s00234-020-02431-x pmid:32306052

    CrossRefPubMed
16. 16.↵
    1. Rutland JW,
    2. Delman BN,
    3. Feldman RE, et al

    . Utility of 7 Tesla MRI for preoperative planning of endoscopic endonasal surgery for pituitary adenomas. J Neurol Surg B Skull Base 2021;82:303–12 doi:10.1055/s-0039-3400222 pmid:34026406

    CrossRefPubMed
17. 17.↵
    1. Yao A,
    2. Rutland JW,
    3. Verma G, et al

    . Pituitary adenoma consistency: direct correlation of ultrahigh field 7T MRI with histopathological analysis. Eur J Radiol 2020;126:108931 doi:10.1016/j.ejrad.2020.108931 pmid:32146344

    CrossRefPubMed
18. 18.↵
    1. Mark IT,
    2. Welker K,
    3. Erickson D, et al

    . 7T MRI for Cushing’s disease: a single institutional experience and literature review. AJNR Am J Neuroradiol 2024;45:971–76 doi:10.3174/ajnr.A8209 pmid:38365424

    Abstract/FREE Full Text
19. 19.↵
    1. Snaar JE,
    2. Teeuwisse WM,
    3. Versluis MJ, et al

    . Improvements in high-field localized MRS of the medial temporal lobe in humans using new deformable high-dielectric materials. NMR Biomed 2011;24:873–79 doi:10.1002/nbm.1638 pmid:21834010

    CrossRefPubMed
20. 20.↵
    1. Fagan AJ,
    2. Bitz AK,
    3. Bjorkman-Burtscher IM, et al

    ; ISMRM Safety Committee. 7T MR safety. J Magn Reson Imaging 2021;53:333–46 doi:10.1002/jmri.27319 pmid:32830900

    CrossRefPubMed
21. 21.↵
    1. Castillo M

    . Pituitary gland: development, normal appearances, and magnetic resonance imaging protocols. Top Magn Reson Imaging 2005;16:259–68 doi:10.1097/01.rmr.0000224682.91253.15 pmid:16785841

    CrossRefPubMed
22. 22.↵
    1. Tortori-Donati P

    1. Tortori-Donati P,
    2. Rossi A,
    3. Biancheri R

    . Sellar and Suprasellar Disorders. In: Tortori-Donati P, ed. Pediatric Neuroradiology. Heidelberg: Springer-Verlag 2005: 855–92
23. 23.↵
    1. Raybaud C,
    2. Barkovich AJ

    1. Raybaud C,
    2. Barkovich AJ

    . Rathke Cleft Cysts. In: Raybaud C, Barkovich AJ, eds. Pediatric Neuroimaging. Philadelphia: Lippincott Williams & Wilkins; 2012:733–34
24. 24.↵
    1. Osborn AG

    1. Osborn AG

    . Rathke Cleft Cyst. In: Osborn AG, ed. Brain. Manitoba, Canada: Amirsys; 2013: 682–99
25. 25.↵
    1. Mahdi ES,
    2. Webb RL,
    3. Whitehead MT

    . Prevalence of pituitary cysts in children using modern magnetic resonance imaging techniques. Pediatr Radiol 2019;49:1781–87 doi:10.1007/s00247-019-04479-1 pmid:31352514

    CrossRefPubMed
26. 26.↵
    1. Gobara A,
    2. Katsube T,
    3. Asou H, et al

    . T2 hypointense signal discovered incidentally at the posterior edge of the adenohypophysis on MRI: its prevalence and morphology and their relationship to age. Neuroradiology 2022;64:1755–61 doi:10.1007/s00234-022-02935-8 pmid:35357532

    CrossRefPubMed
27. 27.↵
    1. Mendoza JW,
    2. Strickland BA,
    3. Micko A, et al

    . Prevalence rate of coexisting Rathke cleft cysts and pineal cysts: a multicenter cross-sectional study. World Neurosurg 2021;149:e455–59 doi:10.1016/j.wneu.2021.02.004 pmid:33567367

    CrossRefPubMed
28. 28.↵
    1. Fliers E,
    2. Korbonits M,
    3. Romijn JA

    1. Larkin S,
    2. Karavitaki N,
    3. Ansorge O

    . Rathke’s cleft cyst. In: Fliers E, Korbonits M, Romijn JA, eds. Handbook of Clinical Neurology. Amsterdam, Netherlands: Elsevier; 2014:255–69
29. 29.↵
    1. Schmidt B,
    2. Cattin F,
    3. Aubry S

    . Prevalence of Rathke cleft cysts in children on magnetic resonance imaging. Diagn Interv Imaging 2020;101:209–15 doi:10.1016/j.diii.2019.12.005 pmid:31953055

    CrossRefPubMed
30. 30.↵
    1. Famini P,
    2. Maya MM,
    3. Melmed S

    . Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 2011;96:1633–41 doi:10.1210/jc.2011-0168 pmid:21470998

    CrossRefPubMed
31. 31.↵
    1. Hoang JK,
    2. Hoffman AR,
    3. González RG, et al

    . Management of Incidental Pituitary Findings on CT, MRI, and ¹⁸F-Fluorodeoxyglucose PET: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiology 2018;15:966–72 doi:10.1016/j.jacr.2018.03.037 pmid:29735244

    CrossRefPubMed